Notice Concerning Differences between the Financial Results Forecasts and the Actual Results | IR News | News Release ＆ IR News | Investor Relations Read more
Notice Concerning Revisions to the Financial Results Forecasts | IR News | News Release ＆ IR News | Investor Relations Read more
Consolidated Financial Results for the Six Months Ended September 30, 2023 (Under Japanese GAAP) | IR News | News Release ＆ IR News | Investor Relations Read more
ANDOVER, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on December 8, 2023, to Read more
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2023 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will present and participate in an analyst moderated question and answer session on behalf of the... Read more
Peabody, MA | Nov. 2, 2023 – JEOL’s JAM-5200EBM Metal 3D Printer, a production ready Electron Beam Powder Bed Fusion (EB-PBF) additive manufacturing solution, has demonstrated the ability to meet the rigorous AMS7032 operational qualification (OQ) standards, while achieving the AMS7011 material requirements for Ti-6Al-4V alloy with post-deposition hot isostatic pressing (HIP). JEOL’s is the... Read more
Q3 2023 revenues of $742.8 million, up 16.3% year-over-year (yoy); organic revenue up 10.9% yoy Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy Bruker increases FY 2023 revenue guidance to $2.88-$2.91 billion; implies reported revenue growth of 14%-15% yoy, and organic revenue growth of 11.5%-12.5% yoy, with organic growth up 150 bps... Read more
Revenue of $932 million, in-line with the midpoint of guidance GAAP gross margin of 45.7% and Non-GAAP gross margin of 47.1%, above the high-end of guidance GAAP operating margin of 12.6% and Non-GAAP operating margin of 21.8%, above the high-end of guidance GAAP net income per diluted share of Read more
Shareholders to Receive $26.00 per Common Share and ADS in Cash WALTHAM, Mass. & UPPSALA, Sweden–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that Thermo Fisher has commenced the previously... Read more
WASHINGTON, Oct. 31, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024. Mr. Riley, currently Vice President and... Read more